Total Payments
$1,215
2023 Payments
$17.61
Companies
9
Transactions
96
Medicare Patients
267
Medicare Billing
$30,138
Payment Breakdown by Category
Food & Beverage$1,040 (85.6%)
Consulting$175.00 (14.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,040 | 95 | 85.6% |
| Consulting Fee | $175.00 | 1 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $309.62 | 31 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $213.75 | 28 | $0 (2017) |
| Alkermes, Inc. | $191.85 | 13 | $0 (2018) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $175.00 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $163.29 | 12 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $91.41 | 6 | $0 (2017) |
| Lundbeck LLC | $28.35 | 2 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $24.00 | 2 | $0 (2018) |
| Indivior Inc. | $17.61 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.61 | 1 | Indivior Inc. ($17.61) |
| 2019 | $59.59 | 2 | Otsuka America Pharmaceutical, Inc. ($45.25) |
| 2018 | $190.37 | 15 | Janssen Pharmaceuticals, Inc ($122.95) |
| 2017 | $947.31 | 78 | Sunovion Pharmaceuticals Inc. ($213.75) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/06/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: BH | ||||||
| 03/29/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $45.25 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Neuroscience | ||||||
| 07/19/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Neuroscience | ||||||
| 06/21/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Neuroscience | ||||||
| 05/30/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Neuroscience | ||||||
| 05/23/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: Neuroscience | ||||||
| 05/15/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Neuroscience | ||||||
| 05/04/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Neuroscience | ||||||
| 04/18/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Neuroscience | ||||||
| 02/28/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: Neuroscience | ||||||
| 02/26/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: CNS | ||||||
| 02/14/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Central Nervous System | ||||||
| 02/09/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CNS | ||||||
| 01/24/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Neuroscience | ||||||
| 01/19/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: CNS | ||||||
| 01/19/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Neuroscience | ||||||
| 01/04/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Neuroscience | ||||||
| 12/15/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: CNS | ||||||
| 12/08/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: CNS | ||||||
| 12/08/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: CNS | ||||||
| 12/06/2017 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Schizophrenia | ||||||
| 12/01/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: CNS | ||||||
| 11/29/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 36 | 100 | $13,201 | $4,329 |
| 2022 | 2 | 68 | 141 | $19,219 | $7,597 |
| 2021 | 3 | 86 | 167 | $20,286 | $9,244 |
| 2020 | 3 | 77 | 144 | $21,027 | $8,968 |
Total Patients
267
Total Services
552
Medicare Billing
$30,138
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 77 | $9,355 | $3,174 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 23 | $3,846 | $1,155 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 61 | $9,699 | $4,275 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 80 | $9,520 | $3,322 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 87 | $10,353 | $4,675 | 45.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 43 | $6,837 | $3,667 | 53.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 37 | $3,096 | $902.75 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 82 | $9,758 | $4,156 | 42.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 45 | $7,155 | $3,164 | 44.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 16 | 17 | $4,114 | $1,649 | 40.1% |
About Dr. Celia Posada, M.D
Dr. Celia Posada, M.D is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1184915985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celia Posada, M.D has received a total of $1,215 in payments from pharmaceutical and medical device companies, with $17.61 received in 2023. These payments were reported across 96 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,040).
As a Medicare-enrolled provider, Posada has provided services to 267 Medicare beneficiaries, totaling 552 services with total Medicare billing of $30,138. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Springfield, MO
- Active Since 04/27/2011
- Last Updated 10/14/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184915985
Products in Payments
- INVEGA SUSTENNA (Drug) $309.62
- LATUDA (Drug) $213.75
- Aristada 441 mg (Drug) $191.85
- ABILIFY MAINTENA (Drug) $98.57
- REXULTI (Drug) $93.07
- Fanapt (Drug) $91.41
- AUSTEDO (Drug) $24.00
- PERSERIS (Drug) $17.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Springfield
Dr. Kalpana Vishnupad, M.d, M.D
Psychiatry — Payments: $63,945
Psychiatry $63,945
Dr. Andrea Stonecipher, M.d, M.D
Psychiatry — Payments: $28,609
Psychiatry $28,609
Dr. Shirlann Knight, M.d, M.D
Psychiatry — Payments: $9,255
Psychiatry $9,255
Dr. Umamaheswara Vellanki, M.d, M.D
Psychiatry — Payments: $9,082
Psychiatry $9,082
Dr. Dennis Dobard, M.d, M.D
Psychiatry — Payments: $8,804
Psychiatry $8,804
Dr. Obiora Onwuameze, Md, Ms, Phd, MD, MS, PHD
Psychiatry — Payments: $6,358
Psychiatry $6,358